Evidence-based, guideline-concordant, office-based shockwave lithotripsy with transparent patient-selection criteria. A straightforward referral pathway for your patients with stones.
Shockwave lithotripsy is a guideline-endorsed option. The 2026 AUA guideline supports URS or SWL for distal ureteral stones ≤10 mm and for proximal ureteral stones <2 cm, with modality selection driven by stone and patient factors and shared decision-making.
For appropriately selected stones, published ESWL stone-free rates are commonly in the range of 75–85% (higher with a second session when needed), with serious complication rates near 1% in large series — and consistently lower complication and auxiliary-procedure rates than ureteroscopy. Our practice's outcomes are consistent with — and, through disciplined case selection, aim to meet or exceed — these published benchmarks. Formal practice-specific outcome data is available on request as our prospective series matures.
Call us at (212) 991-9991, or have your patient send their CT for a candidacy review. We make it easy to get a fast, honest read on whether a given stone is a good ESWL candidate — and we'll tell you when it isn't.
Call us directly, or have your patient reach out for a candidacy review of their imaging.